Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18.46	0.17	2.03	19.56	0.3	10.18
Short-Term Investments	-	0.06	0.05	0.4	0.07	-
Cash & Short-Term Investments	18.46	0.22	2.08	19.96	0.37	10.18
Cash Growth	1168.93%	-89.33%	-89.58%	5353.01%	-96.40%	557.79%
Accounts Receivable	-	-	-	-	-	0.64
Other Receivables	1.65	0.95	0.87	1.35	1.12	10.81
Receivables	1.65	0.95	0.87	1.35	1.12	11.45
Prepaid Expenses	0.15	0.78	0.59	0.04	0.17	0.68
Other Current Assets	0.1	0.02	1.43	0.07	0.05	-
Total Current Assets	20.37	1.97	4.97	21.4	1.72	22.31
Property, Plant & Equipment	0.01	0.02	0.03	0.09	0.35	2.92
Long-Term Investments	-	-	-	-	0.85	-
Other Intangible Assets	-	9.87	9.55	28.14	30.49	155.98
Total Assets	20.38	11.86	14.54	49.63	33.4	181.2
Accounts Payable	4.69	8.42	6.25	0.7	2.12	14.54
Accrued Expenses	1.32	1.31	1.9	8.59	1.84	-
Short-Term Debt	1.34	-	2.64	-	1.41	3.58
Current Portion of Long-Term Debt	-	1.3	-	-	-	-
Current Portion of Leases	-	-	0.01	0.1	0.11	0.57
Current Income Taxes Payable	0.06	0.06	0.04	0.06	0.06	0.29
Other Current Liabilities	0	3.08	0.37	11.27	-	12.52
Total Current Liabilities	7.41	14.17	11.22	20.72	5.53	31.5
Long-Term Debt	-	-	1.08	0.98	0.88	-
Long-Term Leases	-	-	-	0.01	0.27	2.27
Long-Term Deferred Tax Liabilities	-	0.45	0.35	1.96	2.14	6.1
Other Long-Term Liabilities	-	-	-	7.18	0.15	-
Total Liabilities	7.41	14.61	12.65	30.85	8.96	39.87
Common Stock	-	-	-	0	0.43	6.07
Additional Paid-In Capital	125.17	90.37	83.16	85.24	62.48	310.53
Retained Earnings	-111.51	-94.45	-82.55	-66.49	-39.84	-192.97
Comprehensive Income & Other	-0.69	-0.41	-0.72	-0.6	1.38	0.24
Total Common Equity	12.96	-4.49	-0.11	18.15	24.44	123.86
Minority Interest	-	-	-	-	-	17.47
Shareholders' Equity	12.96	-2.75	1.89	18.78	24.44	141.33
Total Liabilities & Equity	20.38	11.86	14.54	49.63	33.4	181.2
Total Debt	1.34	1.3	3.74	1.09	2.67	6.43
Net Cash (Debt)	17.13	-1.08	-1.66	18.87	-2.3	3.75
Net Cash Growth	5846.53%	-	-	-	-	-
Net Cash Per Share	32.54	-	-	-	-	-
Filing Date Shares Outstanding	1.58	0.01	0	0	-	121.34
Total Common Shares Outstanding	1.58	-	0	0	-	121.34
Working Capital	12.95	-12.2	-6.25	0.69	-3.82	-9.19
Book Value Per Share	8.23	-	-5947.37	1815200.00	-	1.02
Tangible Book Value	12.96	-14.36	-9.66	-9.98	-6.05	-32.11
Tangible Book Value Per Share	8.23	-	-508526.32	-998300.00	-	-0.26
Machinery	-	-	-	-	0.36	2.19

Source: S&P Capital IQ. Standard template. Financial Sources.